ProKidney Corp. PROK
1.04 USD -0.02 (-1.89%)
Regular-session close
1.03 -0.01 -0.94%
After hours · Nov 20, 7:25 PM ET
1.02 Day range 1.08
1.04 52-week range 2.57
- YTD
- -53.57%
- 1 year
- -50.24%
News
globenewswire.com ProKidney Names Farah Ali, M.D., M.S., Chief Medical Officer Dr. Ali expands her role at ProKidney, bringing experience as a board-certified pediatric nephrologist and clinical development leader as the Company prepares for anticipated clinical milestones and…benzinga.com ProKidney Q3 EPS $(0.17) Misses $(0.14) Estimate, Sales $174.000K Beat $124.600K Estimate ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 41.67 percent decrease over losses of $(0.12)…
benzinga.com ProKidney Corp. Enters $200 Million At-The-Market Offering Agreement With Jefferies On October 29, 2026, ProKidney Corp. (the "Company") entered into an Open Market Sale AgreementSM (the "Sales Agreement") with Jefferies LLC (the "Sales Agent"), pursuant to which the Company may
benzinga.com Citigroup Maintains Buy on ProKidney, Lowers Price Target to $8 Citigroup analyst Yigal Nochomovitz maintains ProKidney (NASDAQ:PROK) with a Buy and lowers the price target from $10 to $8.
